List of molecules and drugs that target protein P23219

#	DrugDomain Data	DrugBank Accession	Name	Drug action	Affinity data	InChI Key	SMILES
1	P23219_DB00154	DB00154	Dihomo-gamma-linolenic acid	inhibitor		HOBAELRKJCKHQD-QNEBEIHSSA-N	CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O
2	P23219_DB00159	DB00159	Icosapent	inhibitor		JAZBEHYOTPTENJ-JLNKQSITSA-N	CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O
3	P23219_DB00244	DB00244	Mesalazine	inhibitor		KBOPZPXVLCULAV-UHFFFAOYSA-N	NC1=CC(C(O)=O)=C(O)C=C1
4	P23219_DB00316	DB00316	Acetaminophen	inhibitor	Ki(nM) = 10000.0 IC50(nM) = 200000.0	RZVAJINKPMORJF-UHFFFAOYSA-N	CC(=O)NC1=CC=C(O)C=C1
5	P23219_DB00328	DB00328	Indomethacin	inhibitor	Ki(nM) = 13.0 IC50(nM) = 2.0 Kd(nM) = 253.0	CGIGDMFJXJATDK-UHFFFAOYSA-N	COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O
6	P23219_DB00350	DB00350	Minoxidil	inducer		ZFMITUMMTDLWHR-UHFFFAOYSA-N	NC1=CC(=NC(N)=[N+]1[O-])N1CCCCC1
7	P23219_DB00461	DB00461	Nabumetone	inhibitor	Ki(nM) = 10000.0	BLXXJMDCKKHMKV-UHFFFAOYSA-N	COC1=CC2=C(C=C1)C=C(CCC(C)=O)C=C2
8	P23219_DB00465	DB00465	Ketorolac	inhibitor	Ki(nM) = 0.19	OZWKMVRBQXNZKK-UHFFFAOYSA-N	OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1
9	P23219_DB00469	DB00469	Tenoxicam	inhibitor		LZNWYQJJBLGYLT-UHFFFAOYSA-N	CN1C(C(=O)NC2=CC=CC=N2)=C(O)C2=C(C=CS2)S1(=O)=O
10	P23219_DB00500	DB00500	Tolmetin	inhibitor	Ki(nM) = 350.0	UPSPUYADGBWSHF-UHFFFAOYSA-N	CN1C(CC(O)=O)=CC=C1C(=O)C1=CC=C(C)C=C1
11	P23219_DB00554	DB00554	Piroxicam	inhibitor	Ki(nM) = 760.0 IC50(nM) = 1300.0	QYSPLQLAKJAUJT-UHFFFAOYSA-N	CN1C(C(=O)NC2=NC=CC=C2)=C(O)C2=C(C=CC=C2)S1(=O)=O
12	P23219_DB00573	DB00573	Fenoprofen	inhibitor	Ki(nM) = 2730.0	RDJGLLICXDHJDY-UHFFFAOYSA-N	CC(C(O)=O)C1=CC(OC2=CC=CC=C2)=CC=C1
13	P23219_DB00586	DB00586	Diclofenac	inhibitor	IC50(nM) = 3.0	DCOPUUMXTXDBNB-UHFFFAOYSA-N	OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl
14	P23219_DB00605	DB00605	Sulindac	inhibitor		MLKXDPUZXIRXEP-MFOYZWKCSA-N	CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(C=C1)S(C)=O
15	P23219_DB00711	DB00711	Diethylcarbamazine	inhibitor		RCKMWOKWVGPNJF-UHFFFAOYSA-N	CCN(CC)C(=O)N1CCN(C)CC1
16	P23219_DB00712	DB00712	Flurbiprofen	inhibitor	Ki(nM) = 75.0 IC50(nM) = 10.0	SYTBZMRGLBWNTM-UHFFFAOYSA-N	CC(C(O)=O)C1=CC(F)=C(C=C1)C1=CC=CC=C1
17	P23219_DB00749	DB00749	Etodolac	inhibitor	Ki(nM) = 1200.0 IC50(nM) = 10300.0	NNYBQONXHNTVIJ-UHFFFAOYSA-N	CCC1=C2NC3=C(CCOC3(CC)CC(O)=O)C2=CC=C1
18	P23219_DB00784	DB00784	Mefenamic acid	inhibitor	Ki(nM) = 1940.0 IC50(nM) = 25000.0	HYYBABOKPJLUIN-UHFFFAOYSA-N	CC1=C(C)C(NC2=CC=CC=C2C(O)=O)=CC=C1
19	P23219_DB00788	DB00788	Naproxen	inhibitor	IC50(nM) = 8650.0	CMWTZPSULFXXJA-VIFPVBQESA-N	COC1=CC2=C(C=C1)C=C(C=C2)[C@H](C)C(O)=O
20	P23219_DB00795	DB00795	Sulfasalazine	inhibitor		NCEXYHBECQHGNR-QZQOTICOSA-N	OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1
21	P23219_DB00812	DB00812	Phenylbutazone	inhibitor		VYMDGNCVAMGZFE-UHFFFAOYSA-N	CCCCC1C(=O)N(N(C1=O)C1=CC=CC=C1)C1=CC=CC=C1
22	P23219_DB00814	DB00814	Meloxicam	inhibitor	Ki(nM) = 140.0 IC50(nM) = 37.0	ZRVUJXDFFKFLMG-UHFFFAOYSA-N	CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C2=C(C=CC=C2)S1(=O)=O
23	P23219_DB00821	DB00821	Carprofen	inhibitor	Ki(nM) = 87.0 IC50(nM) = 13200.0	PUXBGTOOZJQSKH-UHFFFAOYSA-N	CC(C(O)=O)C1=CC2=C(C=C1)C1=C(N2)C=CC(Cl)=C1
24	P23219_DB00861	DB00861	Diflunisal	inhibitor	Ki(nM) = 10000.0	HUPFGZXOMWLGNK-UHFFFAOYSA-N	OC(=O)C1=C(O)C=CC(=C1)C1=C(F)C=C(F)C=C1
25	P23219_DB00870	DB00870	Suprofen	inhibitor	Ki(nM) = 1100.0 IC50(nM) = 560.0	MDKGKXOCJGEUJW-UHFFFAOYSA-N	CC(C(O)=O)C1=CC=C(C=C1)C(=O)C1=CC=CS1
26	P23219_DB00936	DB00936	Salicylic acid	inhibitor	Ki(nM) = 10000.0 IC50(nM) = 40000.0	YGSDEFSMJLZEOE-UHFFFAOYSA-N	OC(=O)C1=CC=CC=C1O
27	P23219_DB00939	DB00939	Meclofenamic acid	inhibitor	Ki(nM) = 220.0 IC50(nM) = 220.0	SBDNJUWAMKYJOX-UHFFFAOYSA-N	CC1=C(Cl)C(NC2=CC=CC=C2C(O)=O)=C(Cl)C=C1
28	P23219_DB00945	DB00945	Acetylsalicylic acid	inhibitor	Ki(nM) = 1700.0 IC50(nM) = 350.0	BSYNRYMUTXBXSQ-UHFFFAOYSA-N	CC(=O)OC1=CC=CC=C1C(O)=O
29	P23219_DB00963	DB00963	Bromfenac	inhibitor		ZBPLOVFIXSTCRZ-UHFFFAOYSA-N	NC1=C(CC(O)=O)C=CC=C1C(=O)C1=CC=C(Br)C=C1
30	P23219_DB00991	DB00991	Oxaprozin	inhibitor	Ki(nM) = 10000.0 IC50(nM) = 740.0	OFPXSFXSNFPTHF-UHFFFAOYSA-N	OC(=O)CCC1=NC(=C(O1)C1=CC=CC=C1)C1=CC=CC=C1
31	P23219_DB01009	DB01009	Ketoprofen	inhibitor	Ki(nM) = 47.0 IC50(nM) = 2.0	DKYWVDODHFEZIM-UHFFFAOYSA-N	CC(C(O)=O)C1=CC(=CC=C1)C(=O)C1=CC=CC=C1
32	P23219_DB01014	DB01014	Balsalazide	inhibitor		IPOKCKJONYRRHP-FMQUCBEESA-N	OC(=O)CCNC(=O)C1=CC=C(C=C1)\N=N\C1=CC=C(O)C(=C1)C(O)=O
33	P23219_DB01050	DB01050	Ibuprofen	inhibitor	Ki(nM) = 48.0 IC50(nM) = 290.0	HEFNNWSXXWATRW-UHFFFAOYSA-N	CC(C)CC1=CC=C(C=C1)C(C)C(O)=O
34	P23219_DB01283	DB01283	Lumiracoxib	inhibitor	IC50(nM) = 7.0	KHPKQFYUPIUARC-UHFFFAOYSA-N	CC1=CC=C(NC2=C(Cl)C=CC=C2F)C(CC(O)=O)=C1
35	P23219_DB01397	DB01397	Magnesium salicylate	inhibitor		MQHWFIOJQSCFNM-UHFFFAOYSA-L	[Mg++].OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O
36	P23219_DB01399	DB01399	Salsalate	inhibitor	Ki(nM) = 10000.0	WVYADZUPLLSGPU-UHFFFAOYSA-N	OC(=O)C1=CC=CC=C1OC(=O)C1=CC=CC=C1O
37	P23219_DB01401	DB01401	Choline magnesium trisalicylate	inhibitor	Ki(nM) = 10000.0	FQCQGOZEWWPOKI-UHFFFAOYSA-K	[Mg++].C[N+](C)(C)CCO.OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O
38	P23219_DB01419	DB01419	Antrafenine	inhibitor		NWGGKKGAFZIVBJ-UHFFFAOYSA-N	FC(F)(F)C1=CC(=CC=C1)N1CCN(CCOC(=O)C2=CC=CC=C2NC2=C3C=CC(=CC3=NC=C2)C(F)(F)F)CC1
39	P23219_DB01435	DB01435	Antipyrine	inhibitor		VEQOALNAAJBPNY-UHFFFAOYSA-N	CN1N(C(=O)C=C1C)C1=CC=CC=C1
40	P23219_DB01600	DB01600	Tiaprofenic acid	inhibitor		GUHPRPJDBZHYCJ-UHFFFAOYSA-N	CC(C(O)=O)C1=CC=C(S1)C(=O)C1=CC=CC=C1
41	P23219_DB01837	DB01837	O-acetyl-L-serine	n/a		VZXPDPZARILFQX-BYPYZUCNSA-N	CC(=O)OC[C@H](N)C(O)=O
42	P23219_DB01892	DB01892	Hyperforin	inhibitor		IWBJJCOKGLUQIZ-HQKKAZOISA-N	CC(C)C(=O)[C@@]12C(O)=C(CC=C(C)C)C(=O)[C@@](CC=C(C)C)(C[C@H](CC=C(C)C)[C@@]1(C)CCC=C(C)C)C2=O
43	P23219_DB02047	DB02047	(+)-2-(4-biphenyl)propionic acid	n/a		JALUUBQFLPUJMY-NSHDSACASA-N	C[C@H](C(O)=O)C1=CC=C(C=C1)C1=CC=CC=C1
44	P23219_DB02110	DB02110	Protoporphyrin Ix Containing Co	n/a		LUAOCUVKTZELFQ-RGGAHWMASA-N	CC1=C(CCC(O)=O)C2=CC3=C(CCC(O)=O)C(C)=C4C=C5N6C(=CC7=C(C=C)C(C)=C8C=C1N2[Co]6(N34)N78)C(C)=C5C=C
45	P23219_DB02198	DB02198	2-Bromoacetyl Group	n/a		KDPAWGWELVVRCH-UHFFFAOYSA-N	OC(=O)CBr
46	P23219_DB02266	DB02266	Flufenamic acid	n/a	IC50(nM) = 2230.0	LPEPZBJOKDYZAD-UHFFFAOYSA-N	OC(=O)C1=CC=CC=C1NC1=CC(=CC=C1)C(F)(F)F
47	P23219_DB02379	DB02379	Beta-D-Glucose	n/a		WQZGKKKJIJFFOK-VFUOTHLCSA-N	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
48	P23219_DB02709	DB02709	Resveratrol	inhibitor	Ki(nM) = 10000.0 IC50(nM) = 380.0	LUKBXSAWLPMMSZ-OWOJBTEDSA-N	OC1=CC=C(\C=C\C2=CC(O)=CC(O)=C2)C=C1
49	P23219_DB02773	DB02773	(3-Chloro-4-Propoxy-Phenyl)-Acetic Acid	n/a		QEJHPAGTOOIBFT-UHFFFAOYSA-N	CCCOC1=CC=C(CC(O)=O)C=C1Cl
50	P23219_DB03667	DB03667	Acetic Acid Salicyloyl-Amino-Ester	n/a		PCFWLDHLJWUGSU-UHFFFAOYSA-N	CC(=O)ONC(=O)C1=C(O)C=CC=C1
51	P23219_DB03752	DB03752	P-(2'-Iodo-5'-Thenoyl)Hydrotropic Acid	n/a		UIZPHGUBGPJBAR-QMMMGPOBSA-N	[H][C@@](C)(C(O)=O)C1=CC=C(C=C1)C(=O)C1=CC=C(I)S1
52	P23219_DB03753	DB03753	Flurbiprofen Methyl Ester	n/a		CPJBKHZROFMSQM-NSHDSACASA-N	COC(=O)[C@@H](C)C1=CC=C(C(F)=C1)C1=CC=CC=C1
53	P23219_DB03783	DB03783	Phenacetin	n/a		CPJSUEIXXCENMM-UHFFFAOYSA-N	CCOC1=CC=C(NC(C)=O)C=C1
54	P23219_DB04552	DB04552	Niflumic acid	n/a	Ki(nM) = 10000.0	JZFPYUNJRRFVQU-UHFFFAOYSA-N	OC(=O)C1=C(NC2=CC=CC(=C2)C(F)(F)F)N=CC=C1
55	P23219_DB04557	DB04557	Arachidonic Acid	n/a		YZXBAPSDXZZRGB-DOFZRALJSA-N	CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O
56	P23219_DB04817	DB04817	Metamizole	n/a		LVWZTYCIRDMTEY-UHFFFAOYSA-N	CN(CS(O)(=O)=O)C1=C(C)N(C)N(C1=O)C1=CC=CC=C1
57	P23219_DB06725	DB06725	Lornoxicam	inhibitor		WLHQHAUOOXYABV-UHFFFAOYSA-N	CN1C(C(=O)NC2=CC=CC=N2)=C(O)C2=C(C=C(Cl)S2)S1(=O)=O
58	P23219_DB06736	DB06736	Aceclofenac	inhibitor		MNIPYSSQXLZQLJ-UHFFFAOYSA-N	OC(=O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl
59	P23219_DB06802	DB06802	Nepafenac	inhibitor		QEFAQIPZVLVERP-UHFFFAOYSA-N	NC(=O)CC1=CC=CC(C(=O)C2=CC=CC=C2)=C1N
60	P23219_DB07981	DB07981	2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1R)-1-(hydroxymethyl)propyl]acetamide	n/a		GKJWXEORYGBJFS-QGZVFWFLSA-N	CC[C@H](CO)NC(=O)CC1=C(C)N(C(=O)C2=CC=C(Cl)C=C2)C2=CC=C(OC)C=C12
61	P23219_DB07983	DB07983	1-(4-IODOBENZOYL)-5-METHOXY-2-METHYL INDOLE-3-ACETIC ACID	n/a		CXBFZYKAVCAPSV-UHFFFAOYSA-N	COC1=CC=C2N(C(=O)C3=CC=C(I)C=C3)C(C)=C(CC(O)=O)C2=C1
62	P23219_DB07984	DB07984	2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1S)-1-(hydroxymethyl)propyl]acetamide	n/a		GKJWXEORYGBJFS-KRWDZBQOSA-N	CC[C@@H](CO)NC(=O)CC1=C(C)N(C(=O)C2=CC=C(Cl)C=C2)C2=C1C=C(OC)C=C2
63	P23219_DB08814	DB08814	Triflusal	antagonist		RMWVZGDJPAKBDE-UHFFFAOYSA-N	CC(=O)OC1=C(C=CC(=C1)C(F)(F)F)C(O)=O
64	P23219_DB09061	DB09061	Cannabidiol	inhibitor		QHMBSVQNZZTUGM-ZWKOTPCHSA-N	CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1
65	P23219_DB09212	DB09212	Loxoprofen	antagonist	IC50(nM) = 6500.0	YMBXTVYHTMGZDW-UHFFFAOYSA-N	CC(C(O)=O)C1=CC=C(CC2CCCC2=O)C=C1
66	P23219_DB09213	DB09213	Dexibuprofen	inhibitor	IC50(nM) = 99.0	HEFNNWSXXWATRW-JTQLQIEISA-N	CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
67	P23219_DB09214	DB09214	Dexketoprofen	antagonist	IC50(nM) = 1.9	DKYWVDODHFEZIM-NSHDSACASA-N	[H][C@@](C)(C(O)=O)C1=CC(=CC=C1)C(=O)C1=CC=CC=C1
68	P23219_DB09215	DB09215	Droxicam	inhibitor		OEHFRZLKGRKFAS-UHFFFAOYSA-N	CN1C2=C(OC(=O)N(C2=O)C2=CC=CC=N2)C2=CC=CC=C2S1(=O)=O
69	P23219_DB09216	DB09216	Tolfenamic acid	antagonist		YEZNLOUZAIOMLT-UHFFFAOYSA-N	CC1=C(Cl)C=CC=C1NC1=CC=CC=C1C(O)=O
70	P23219_DB09288	DB09288	Propacetamol	antagonist		QTGAJCQTLIRCFL-UHFFFAOYSA-N	CCN(CC)CC(=O)OC1=CC=C(NC(C)=O)C=C1
71	P23219_DB09295	DB09295	Talniflumate	antagonist		ANMLJLFWUCQGKZ-UHFFFAOYSA-N	FC(F)(F)C1=CC(NC2=C(C=CC=N2)C(=O)OC2OC(=O)C3=CC=CC=C23)=CC=C1
72	P23219_DB11071	DB11071	Phenyl salicylate	antagonist		ZQBAKBUEJOMQEX-UHFFFAOYSA-N	OC1=CC=CC=C1C(=O)OC1=CC=CC=C1
73	P23219_DB11079	DB11079	Trolamine salicylate	inhibitor		UEVAMYPIMMOEFW-UHFFFAOYSA-N	OCCN(CCO)CCO.OC(=O)C1=CC=CC=C1O
74	P23219_DB11201	DB11201	Menthyl salicylate	antagonist		SJOXEWUZWQYCGL-DVOMOZLQSA-N	CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1O
75	P23219_DB11323	DB11323	Glycol salicylate	antagonist		LVYLCBNXHHHPSB-UHFFFAOYSA-N	OCCOC(=O)C1=CC=CC=C1O
76	P23219_DB12445	DB12445	Nitroaspirin	inhibitor		IOJUJUOXKXMJNF-UHFFFAOYSA-N	CC(=O)OC1=CC=CC=C1C(=O)OC1=CC=CC(CO[N+]([O-])=O)=C1
77	P23219_DB13346	DB13346	Bufexamac	inhibitor		MXJWRABVEGLYDG-UHFFFAOYSA-N	CCCCOC1=CC=C(CC(=O)NO)C=C1
78	P23219_DB13501	DB13501	Bendazac	n/a		BYFMCKSPFYVMOU-UHFFFAOYSA-N	OC(=O)COC1=NN(CC2=CC=CC=C2)C2=CC=CC=C12
79	P23219_DB13783	DB13783	Acemetacin	antagonist		FSQKKOOTNAMONP-UHFFFAOYSA-N	COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(=O)OCC(O)=O
80	P23219_DB14011	DB14011	Nabiximols	inhibitor		SSNHGLKFJISNTR-DYSNNVSPSA-N	[H][C@]1(CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1O)C(C)=C.[H][C@@]12CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1OC2(C)C